LMO3 Activators
LMO3 activators encompass a range of chemical compounds that can either directly enhance the functional activity of LMO3 or indirectly trigger signaling events leading to its activation. These compounds operate primarily via the cAMP-dependent protein kinase (PKA) pathway, a signaling cascade that LMO3 is known to interact with. Forskolin, Isoproterenol, Rolipram, IBMX, Epinephrine, Norepinephrine, PGE2, Papaverine, Dobutamine, and Terbutaline enhance the functional activity of LMO3 by increasing intracellular cAMP levels, which in turn can activate PKA. PKA is known to interact with LMO3 and can enhance its functional activity.
In contrast, H-89 and SQ 22536 can lead to a decrease in the phosphorylation of proteins that interact with LMO3 due to their inhibitory effects on PKA and adenylate cyclase, respectively. However, this decrease in phosphorylation can lead to the enhancement of the functional activity of LMO3. This illustrates the complex interplay of regulatory mechanisms in cellular signaling pathways. Although these compounds have inhibitory effects on certain enzymes or pathways, they can indirectly enhance the functional activity of LMO3 by triggering these feedback mechanisms. These diverse compounds, by acting on different components of the same pathway, collectively contribute to the functional activation of LMO3.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, leading to increased levels of cyclic AMP (cAMP). Higher cAMP levels can trigger the cAMP-dependent protein kinase (PKA) pathway, which is known to interact with the LMO3 protein, enhancing its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic receptor agonist. Activation of these receptors increases intracellular cAMP, which can stimulate PKA. PKA is known to interact with and enhance the functional activity of LMO3. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a potent inhibitor of phosphodiesterase 4 (PDE4), which results in an increase in cAMP levels. By increasing cAMP, rolipram triggers PKA, which can enhance the functional activity of LMO3. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, raising cellular cAMP levels. Increased cAMP triggers PKA, which in turn can enhance the functional activity of LMO3. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine is a hormone that activates beta-adrenergic receptors. This receptor activation increases cAMP levels, which can stimulate PKA. PKA can enhance the functional activity of LMO3. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine is a hormone that activates beta-adrenergic receptors. This receptor activation increases cAMP levels, which can stimulate PKA. PKA can enhance the functional activity of LMO3. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 is a prostaglandin that stimulates adenylate cyclase to increase cAMP levels. The resulting cAMP accumulation triggers PKA, which can enhance the functional activity of LMO3. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
SQ 22536 is an adenylate cyclase inhibitor. The inhibition of adenylate cyclase reduces cAMP levels, which decreases PKA activity. This decrease in PKA activity can enhance the functional activity of LMO3. | ||||||
Papaverine | 58-74-2 | sc-279951 sc-279951A sc-279951B | 10 mg 50 mg 100 mg | $153.00 $265.00 $459.00 | ||
Papaverine is a PDE inhibitor that raises cellular cAMP levels. Higher cAMP levels trigger PKA, which can enhance the functional activity of LMO3. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Dobutamine is a beta-1 adrenergic receptor agonist that can increase cAMP levels, which in turn stimulate PKA. PKA can enhance the functional activity of LMO3. | ||||||